[Cancer Treatment and Research] Acute Myelogenous Leukemia Volume 145 || Acute Promyelocytic Leukemia: A Paradigm for Differentiation Therapy

[Cancer Treatment and Research] Acute My

[Cancer Treatment and Research] Acute Myelogenous Leukemia Volume 145 || Epigenetic Mechanisms in AML – A Target for Therapy

✍ Nagarajan, Lalitha 📂 Article 📅 2009 🏛 Springer New York 🌐 English ⚖ 489 KB

Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as

[Cancer Treatment and Research] Acute My

[Cancer Treatment and Research] Acute Myelogenous Leukemia Volume 145 || Apoptosis in Leukemias: Regulation and Therapeutic Targeting

✍ Nagarajan, Lalitha 📂 Article 📅 2009 🏛 Springer New York 🌐 English ⚖ 761 KB

Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as

[Cancer Treatment and Research] Acute My

[Cancer Treatment and Research] Acute Myelogenous Leukemia Volume 145 || Lineage-Specific Transcription Factor Aberrations in AML

✍ Nagarajan, Lalitha 📂 Article 📅 2009 🏛 Springer New York 🌐 English ⚖ 553 KB

Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as

[Cancer Treatment and Research] Acute My

[Cancer Treatment and Research] Acute Myelogenous Leukemia Volume 145 || Genes Predictive of Outcome and Novel Molecular Classification Schemes in Adult Acute Myeloid Leukemia

✍ Nagarajan, Lalitha 📂 Article 📅 2009 🏛 Springer New York 🌐 English ⚖ 543 KB

Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as

[Cancer Treatment and Research] Acute My

[Cancer Treatment and Research] Acute Myelogenous Leukemia Volume 145 || Chromosomal Translocations in AML: Detection and Prognostic Significance

✍ Nagarajan, Lalitha 📂 Article 📅 2009 🏛 Springer New York ⚖ 615 KB

A novel differentiation-inducing therapy

A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF

✍ Muto, A; Kizaki, M; Kawamura, C; Matsushita, H; Fukuchi, Y; Umezawa, A; Yamada, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 957 KB